HOTTIP predicts low survival in gastric cancer and promotes B-cell lymphoma 2 (BCL-2) expression by binding miRNA-216a-5p, thereby reducing autophagy-related death and promoting cisplatin resistance in gastric cancer cells [12]. Here, BCL2 is linked to gastric cancer.